Testing for the human leukocyte antigen HLA - B * 5801 allele before
initiating allopurinol was found to be cost effective for black and Asian patients but not for white or Hispanic patients, according to results of a cost - effectiveness analysis published in Seminars in Arthritis and Rheumatism.